SUNSTONE HOTEL INVESTORS INC (SHO)       10.99  +0.21 (+1.95%)

10.99  +0.21 (+1.95%)

US8678921011 - REIT - After market: 10.99 0 (0%)


Fundamental Rating

6

Taking everything into account, SHO scores 6 out of 10 in our fundamental rating. SHO was compared to 217 industry peers in the Equity Real Estate Investment Trusts (REITs) industry. While SHO has a great health rating, its profitability is only average at the moment. SHO is not priced too expensively while it is growing strongly. Keep and eye on this one!




Profitability

Profitability Rating

6

SHO's Return On Assets of 6.68% is amongst the best returns of the industry. SHO outperforms 82% of its industry peers. The industry average Return On Assets is 2.86%.
SHO has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for SHO.

SHO has a Return On Equity of 9.88%. This is comparable to the industry average of 9.38%.
SHO has a Profit Margin of 24.69%. This is comparable to the industry average of 23.60%.
VS Industry

ROA (6.68%) VS Industry: 82% outperformed.

-23.51
29.19

ROE (9.88%) VS Industry: 51% outperformed.

0.07
125.88

Profit Margin (24.69%) VS Industry: 51% outperformed.

-612.10
288.50

Valuation

Valuation Rating

4

SHO's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average industry Enterprise Value to EBITDA ratio of 17.27, SHO is valued rather cheaply
With a price book ratio of 1.10, SHO is valued correctly.
Compared to an average industry price book ratio of 1.25, SHO is valued in line with its industry peers.

The Price/Earnings Ratio is 54.95, which means the current valuation is very expensive for SHO.
Compared to an average industry Price/Earning Ratio of 24.58, SHO is valued more expensive than its industry peers. On top of this 80% of the companies listed in the same industry are cheaper than SHO!
With a Forward Price/Earnings Ratio of 30.33, SHO is valued very expensively.
VS Industry

Price/Earnings (54.95) VS Industry: 20% outperformed.

326.00
0.89

Price/Book (1.1) VS Industry: 58% outperformed.

97.89
0.08

Enterprise Value/ EBITDA (15.73) VS Industry: 61% outperformed.

142.10
5.80

Growth

Growth Rating

7

SHO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 121.51%, which is quite impressive.
The Earnings Per Share is expected to grow by 21.82% on average over the next 5 years. This is a very strong growth
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue has grown by 125.91% in the past year. This is a very strong growth!

Based on estimates for the next 5 years, SHO will show a quite strong growth in Revenue. The Revenue will grow by 14.54% on average per year.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The earnings per share for SHO have been decreasing by -23.97% on average. This is quite bad
SHO shows a very negative growth in Revenue. Measured over the last 5 years, the Revenue has been decreasing by -15.61% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-23.97% -47.7% 121.51% 150.5% 60.47% 37.32% 21.82%
Revenue-15.61% -23.98% 125.91% 72.3% 37.98% 24.21% 14.54%

Health

Health Rating

8

SHO is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 0.44. SHO has a better rating than 86% of its industry peers.
The Quick Ratio of SHO is much better than the industry average of 0.44. SHO has a better rating than 86% of its industry peers.
With a Debt to Equity ratio of 0.39, SHO is one of the better performing companies in its industry. It outperforms 94% of its industry peers.
The Altman-Z score of SHO is much better than the industry average of 0.87.

SHO has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for SHO.
A Current Ratio of 1.36 indicates that SHO should not have too much problems paying its short term obligations.
A Quick Ratio of 1.36 indicates that SHO should not have too much problems paying its short term obligations.
An Altman-Z score of 2.17 indicates that SHO is not a great score, but indicates only limited risk for bankruptcy at the moment.
VS Industry

Debt/Equity (0.39) VS Industry: 94% outperformed.

69.38
0.00

Quick Ratio (1.36) VS Industry: 86% outperformed.

0.05
22.38

Current Ratio (1.36) VS Industry: 86% outperformed.

0.05
22.38

Altman-Z (2.17) VS Industry: 77% outperformed.

-0.55
8.49

Dividend

Dividend Rating

4

SHO pays out 6.74% of its income as dividend. This is a sustainable payout ratio.
SHO has been paying a dividend for at least 10 years, so it has a reliable track record.
SHO has a Yearly Dividend Yield of 1.88%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 4.85, SHO's dividend is way lower than its industry peers. On top of this 94% of the companies listed in the same industry pay a better dividend than SHO!
SHO's Dividend Yield is slightly below the S&P500 average, which is at 2.47.
VS Industry

Dividend Yield (1.88%) VS Industry: 6% outperformed.

0.25
14.90
SHO Daily chart

SUNSTONE HOTEL INVESTORS INC10.99

NYSE:SHO (11/30/2022, 7:04:00 PM)+0.21 (+1.95%)

After market: 10.99 0 (0%)

Chartmill FA Rating
GICS Sector Real Estate
GICS IndustryGroup Real Estate
GICS Industry Equity Real Estate Investment Trusts (REITs)
Earnings (Last) 11-08 2022-11-08/bmo Earnings (Next) 02-20 2023-02-20
Ins Owners 0.88% Inst Owners 113.04%
Market Cap 2.31B Analysts 50.53
Valuation
PE 54.95 Fwd PE 30.33
PEG (NY) 0.37 PEG (5Y) N/A
P/S 2.75 P/B 1.1
EV/EBITDA 15.73
Dividend
Dividend Yield 1.88% Dividend Growth N/A
DP 6.74% Ex-Date 09-29 2022-09-29 (0.05)
Growth
EPS 1Y 121.51% EPS 3Y -47.7%
EPS 5Y -23.97% EPS growth Q2Q 161.54%
EPS Next Y 150.5% EPS Next 2Y 60.47%
EPS Next 3Y 37.32% EPS Next 5Y 21.82%
Revenue growth 1Y 125.91% Revenue growth 3Y -23.98%
Revenue growth 5Y -15.61% Revenue growth Q2Q 45.93%
Revenue Next Year 72.3% Revenue Next 2Y 37.98%
Revenue Next 3Y 24.21% Revenue Next 5Y 14.54%
Health
Current Ratio 1.36 Quick Ratio 1.36
Altman-Z 2.17 F-Score 7
Debt/Equity 0.39 WACC 8.43%
ROIC/WACC 0.21
Profitability
ROA 6.68% ROE 9.88%
ROICexgc 1.73% ROIC 1.66%
PM 24.69% OM 7.34%
Asset Turnover 0.27

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA